Cipla Q3 revenue up by 13pc at Rs 4371 crore Medical Dialogues Bureau6 Feb 2020 12:30 PM IST "We have had yet another good quarter: India business continued its momentum with strong double-digit growth in the prescription business; growth...
Price-Fixing Conspiracies: Taro Pharma former executive faces probe in US Medical Dialogues Bureau6 Feb 2020 12:00 PM IST The Justice Department said that former sales and marketing executive of Taro Pharma, Aprahamian was indicted on Tuesday for participating in two...
Sanofi being probed over birth defects related to Epilepsy drug Depakine Medical Dialogues Bureau5 Feb 2020 3:35 PM IST The Paris prosecutor had already launched a preliminary investigation into the authorisation and marketing of Depakine in 2016, after France's...
JnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar Choubey Medical Dialogues Bureau5 Feb 2020 3:15 PM IST "Based on the court order, a list of verified claimants along with supporting documents has been provided to Johnson and Johnson for complying with...
Granules India arm gets USFDA nod for generic version of Valcyte Medical Dialogues Bureau5 Feb 2020 3:13 PM IST Valganciclovir hydrochloride oral solution is bioequivalent to the reference listed drug product (RLD), Valcyte for Oral Solution, 50mg/mL, OF Roche...
Sun Pharma unveils acne drug Absorica LD in US Medical Dialogues Bureau5 Feb 2020 11:41 AM IST "The launch of Absorica LD - which offers the proven efficacy and safety of Absorica at a lower dose - underscores our commitment to making a...
Cadila Healthcare Ahmedabad facility clears USFDA inspection Farhat Nasim5 Feb 2020 9:15 AM IST United States Food and Drug Administration (USFDA) inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned...
NPPA pulls Gilead on price exemption plea for its Hepatitis B drug Farhat Nasim4 Feb 2020 3:12 PM ISTNew Delhi: The apex drug price regulator, National Pharmaceuticals Pricing Authority (NPPA) has recently sought clarifications from the US-drugmaker...
Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium Farhat Nasim4 Feb 2020 10:30 AM IST"Zydus Cadila has received the approval from the Drug Controller General of India (DCGI) for use of Saroglitazar Mg in the treatment of type II...
Divis Labs Chippada facility gets zero USFDA observations Medical Dialogues Bureau4 Feb 2020 9:45 AM IST "This is to inform you that the Company's Unit-II at Village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the US Food...
GSK, CEPI collaborate to develop vaccine for 2019-nCoV virus Medical Dialogues Bureau4 Feb 2020 9:30 AM IST Both CEPI and GSK are committed to principles of equitable access and will work together in this collaboration to ensure that this principle governs...
Eli Lilly to provide Migraine drug Reyvow Farhat Nasim4 Feb 2020 9:00 AM ISTNew Delhi: Eli Lilly and Company announced recently that REYVOW (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment...
